Results
Revise Search
Essential drugs for the exclusive use of developing countries
https://policybase.cma.ca/en/permalink/policy415
- Last Reviewed
- 2014-03-01
- Date
- 2000-08-16
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Population health/ health equity/ public health
- Resolution
- GC00-221
- The CMA calls on governments and pharmaceutical manufacturers in Canada to ensure a supply of essential drugs for the exclusive use of developing countries, and to offset the numerous barriers hindering access to these drugs.
- Policy Type
- Policy resolution
- Last Reviewed
- 2014-03-01
- Date
- 2000-08-16
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Population health/ health equity/ public health
- Resolution
- GC00-221
- The CMA calls on governments and pharmaceutical manufacturers in Canada to ensure a supply of essential drugs for the exclusive use of developing countries, and to offset the numerous barriers hindering access to these drugs.
Psycho-active substances and the operation of motor vehicles and industrial equipment
https://policybase.cma.ca/en/permalink/policy781
- Last Reviewed
- 2017-03-04
- Date
- 1973-06-16
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Population health/ health equity/ public health
- Resolution
- GC73-50
- That the membership of the Canadian Medical Association clearly inform its patients, and the general public at large, of the hazards associated with the operation of motor vehicles, industrial equipment, etc., while under the influence of psycho-active substances, especially alcohol and antihistamines, and particularly the combination of such substances.
- Policy Type
- Policy resolution
- Last Reviewed
- 2017-03-04
- Date
- 1973-06-16
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Population health/ health equity/ public health
- Resolution
- GC73-50
- That the membership of the Canadian Medical Association clearly inform its patients, and the general public at large, of the hazards associated with the operation of motor vehicles, industrial equipment, etc., while under the influence of psycho-active substances, especially alcohol and antihistamines, and particularly the combination of such substances.
Pan-Canadian standardized vaccination protocol
https://policybase.cma.ca/en/permalink/policy10474
- Last Reviewed
- 2019-03-03
- Date
- 2012-08-15
- Topics
- Population health/ health equity/ public health
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Resolution
- GC12-63
- The Canadian Medical Association calls for the development of a pan-Canadian standardized vaccination protocol.
- Policy Type
- Policy resolution
- Last Reviewed
- 2019-03-03
- Date
- 2012-08-15
- Topics
- Population health/ health equity/ public health
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Resolution
- GC12-63
- The Canadian Medical Association calls for the development of a pan-Canadian standardized vaccination protocol.
Coverage for all forms of contraception
https://policybase.cma.ca/en/permalink/policy10533
- Last Reviewed
- 2019-03-03
- Date
- 2012-08-15
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Population health/ health equity/ public health
- Resolution
- GC12-113
- The Canadian Medical Association supports full coverage for all forms of contraception.
- Policy Type
- Policy resolution
- Last Reviewed
- 2019-03-03
- Date
- 2012-08-15
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Population health/ health equity/ public health
- Resolution
- GC12-113
- The Canadian Medical Association supports full coverage for all forms of contraception.
Drug manufacturing and distribution
https://policybase.cma.ca/en/permalink/policy10535
- Last Reviewed
- 2019-03-03
- Date
- 2012-08-15
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Population health/ health equity/ public health
- Resolution
- GC12-115
- The Canadian Medical Association calls for the modernization of the federal Food and Drugs Act relating to drug manufacturing and distribution processes.
- Policy Type
- Policy resolution
- Last Reviewed
- 2019-03-03
- Date
- 2012-08-15
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Population health/ health equity/ public health
- Resolution
- GC12-115
- The Canadian Medical Association calls for the modernization of the federal Food and Drugs Act relating to drug manufacturing and distribution processes.
Recommendations pertaining to children's mental health
https://policybase.cma.ca/en/permalink/policy8507
- Last Reviewed
- 2020-02-29
- Date
- 2006-08-23
- Topics
- Health systems, system funding and performance
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Population health/ health equity/ public health
- Resolution
- GC06-15
- The Canadian Medical Association endorses all of the recommendations pertaining to children's mental health in the Senate report, Out of the Shadows at Last - Transforming Mental Health, Mental Illness and Addiction Services in Canada.
- Policy Type
- Policy resolution
- Last Reviewed
- 2020-02-29
- Date
- 2006-08-23
- Topics
- Health systems, system funding and performance
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Population health/ health equity/ public health
- Resolution
- GC06-15
- The Canadian Medical Association endorses all of the recommendations pertaining to children's mental health in the Senate report, Out of the Shadows at Last - Transforming Mental Health, Mental Illness and Addiction Services in Canada.
Insurance fund of last resort
https://policybase.cma.ca/en/permalink/policy8520
- Last Reviewed
- 2020-02-29
- Date
- 2006-08-23
- Topics
- Population health/ health equity/ public health
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Resolution
- GC06-16
- The Canadian Medical Association urges governments to create an insurance fund of last resort to provide financial relief to parents for the catastrophic cost of drugs and other health care services provided to children as part of an accepted treatment protocol for childhood illnesses and disorders when not covered by public insurance.
- Policy Type
- Policy resolution
- Last Reviewed
- 2020-02-29
- Date
- 2006-08-23
- Topics
- Population health/ health equity/ public health
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Resolution
- GC06-16
- The Canadian Medical Association urges governments to create an insurance fund of last resort to provide financial relief to parents for the catastrophic cost of drugs and other health care services provided to children as part of an accepted treatment protocol for childhood illnesses and disorders when not covered by public insurance.
Sale of clove, herbal and vitamin cigarettes
https://policybase.cma.ca/en/permalink/policy8547
- Last Reviewed
- 2020-02-29
- Date
- 2006-08-23
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Population health/ health equity/ public health
- Resolution
- GC06-77
- The Canadian Medical Association will work with the federal government to study the possibility of national legislation governing the promotion and sale of clove, herbal and vitamin cigarettes.
- Policy Type
- Policy resolution
- Last Reviewed
- 2020-02-29
- Date
- 2006-08-23
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Population health/ health equity/ public health
- Resolution
- GC06-77
- The Canadian Medical Association will work with the federal government to study the possibility of national legislation governing the promotion and sale of clove, herbal and vitamin cigarettes.
Pharmacists who are given independent prescribing authority
https://policybase.cma.ca/en/permalink/policy8557
- Last Reviewed
- 2020-02-29
- Date
- 2006-08-23
- Topics
- Population health/ health equity/ public health
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Health care and patient safety
- Resolution
- GC06-67
- The Canadian Medical Association, in conjunction with its divisions and affiliates, without endorsing pharmacist independent prescribing strongly urges the Government of Alberta to require pharmacists who are given independent prescribing authority to: a) require explicit, informed consent from a patient; b) maintain a patient's record; c) provide 24-hour availability to the patient; d) carry appropriate coverage for legal liability; e) disclose any potential conflict of interest as both a prescriber and dispenser of medication; and, f) if the pharmacist changes a physician's prescription, advise the physician of the change(s).
- Policy Type
- Policy resolution
- Last Reviewed
- 2020-02-29
- Date
- 2006-08-23
- Topics
- Population health/ health equity/ public health
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Health care and patient safety
- Resolution
- GC06-67
- The Canadian Medical Association, in conjunction with its divisions and affiliates, without endorsing pharmacist independent prescribing strongly urges the Government of Alberta to require pharmacists who are given independent prescribing authority to: a) require explicit, informed consent from a patient; b) maintain a patient's record; c) provide 24-hour availability to the patient; d) carry appropriate coverage for legal liability; e) disclose any potential conflict of interest as both a prescriber and dispenser of medication; and, f) if the pharmacist changes a physician's prescription, advise the physician of the change(s).